Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjan Gharagozloo

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Genetics|May 7, 2005
Coincident natural selection of CCR5Delta32 and C282Y in Europe: to be or not to be?Marjan Gharagozloo, Abbas Ghaderi
Journal of Cancer Research and Clinical Oncology|April 17, 2007
Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cellsMarjan Gharagozloo, Zahra Amirghofran
Annals of Hematology|August 12, 2008
Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activityMarjan Gharagozloo, Mehran Karimi, Zahra Amirghofran
Iranian Journal of Immunology : IJI|March 19, 2009
The influence of iron loading and iron chelation on the proliferation and telomerase activity of human peripheral blood mononuclear cellsBahram Bagherpour, Marjan Gharagozloo, Behjat Moayedi
European Journal of Pharmacology|July 16, 2008
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamineMarjan Gharagozloo, Zahra Khoshdel, Zahra Amirghofran
International Immunopharmacology|April 30, 2013
Immunomodulatory effects of silymarin in patients with β-thalassemia majorMarjan Gharagozloo, Mehran Karimi, Zahra Amirghofran
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2015
Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance inductionMarjan Gharagozloo, Slawomir Majewski, Marianna Foldvari
Current Opinion in Pharmacology|March 7, 2022
Breaking the barriers to remyelination in multiple sclerosisMarjan Gharagozloo, Riley Bannon, Peter A Calabresi
Frontiers in Molecular Neuroscience|November 21, 2022
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosisMarjan Gharagozloo, Jackson W Mace, Peter A Calabresi
American Journal of Clinical and Experimental Immunology|March 25, 2014
Dust events, pulmonary diseases and immune systemNafiseh Esmaeil, Marjan Gharagozloo, Abbas Rezaei, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Genetics|May 7, 2005
Coincident natural selection of CCR5Delta32 and C282Y in Europe: to be or not to be?Marjan Gharagozloo, Abbas Ghaderi
Journal of Cancer Research and Clinical Oncology|April 17, 2007
Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cellsMarjan Gharagozloo, Zahra Amirghofran
Annals of Hematology|August 12, 2008
Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activityMarjan Gharagozloo, Mehran Karimi, Zahra Amirghofran
Iranian Journal of Immunology : IJI|March 19, 2009
The influence of iron loading and iron chelation on the proliferation and telomerase activity of human peripheral blood mononuclear cellsBahram Bagherpour, Marjan Gharagozloo, Behjat Moayedi
European Journal of Pharmacology|July 16, 2008
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamineMarjan Gharagozloo, Zahra Khoshdel, Zahra Amirghofran
International Immunopharmacology|April 30, 2013
Immunomodulatory effects of silymarin in patients with β-thalassemia majorMarjan Gharagozloo, Mehran Karimi, Zahra Amirghofran
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2015
Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance inductionMarjan Gharagozloo, Slawomir Majewski, Marianna Foldvari
Current Opinion in Pharmacology|March 7, 2022
Breaking the barriers to remyelination in multiple sclerosisMarjan Gharagozloo, Riley Bannon, Peter A Calabresi
Frontiers in Molecular Neuroscience|November 21, 2022
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosisMarjan Gharagozloo, Jackson W Mace, Peter A Calabresi
American Journal of Clinical and Experimental Immunology|March 25, 2014
Dust events, pulmonary diseases and immune systemNafiseh Esmaeil, Marjan Gharagozloo, Abbas Rezaei, et al.
Pageof 7